Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious diseases. Our medicines reach more than 250 million people worldwide.

Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, and Instagram.

Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn. For questions on the corporate boilerplate, please contact COMMUNICATIONS_CORPORATE@lilly.com.

Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. In recognising our endeavor to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.

Gilead and Kite Oncology are working to transform how cancer is treated. We’re innovating with next-generation therapies, combinations and technologies to deliver improved outcomes for people with cancer. We’re rethinking what's possible to achieve profound effects and, even potentially, cures.

Alphamed, founded in 1982 by Dr. Saad F. Al Khayyat, has emerged as a distinguished leader in the healthcare sector within the United Arab Emirates. With over 42+ years of unwavering commitment, Alphamed has positioned itself as one of the largest and most reputable medical companies in the region. The company takes pride in its extensive range of medical and surgical services, acting as a distribution partner for some of the world's leading manufacturers. Alphamed has forged strong partnerships with renowned global healthcare entities, including Boston Scientific, 3M, Avanos, Stryker, Fujifilm, Getinge, Paxman Scalp Cooling, Bio-Rad & Zeiss, and many more. These collaborations empower Alphamed to deliver state-of-the-art healthcare solutions, incorporating cutting-edge technologies and innovations from the world's leading manufacturers.

Paxman Scalp Cooling has been pioneering scalp cooling technology for over a quarter of a century to support patients and minimize hair loss during chemotherapy. Our clinically proven scalp cooling system helps tens of thousands of cancer patients every year, in more than 60 countries worldwide, to retain their hair during chemotherapy.

At Advamed and its affiliated companies both our customers and partners are the center of our focus. Since launching in 2010, our ultimate goal is providing customers in the region with superior, state-of-the art products that would best fit their needs. As we continue to grow, we remain pioneers through our commitment to quality and our relentless pursuit for excellence. Over the years, we have successfully reached many milestones that we have set for ourselves in terms of financial strength, specialization and geographic coverage which could not have been achieved without a team of dedicated and dynamic individuals who are always eager to improve. We aim to exceed expectations; we are proud of our present and optimistic about our future.

The journey began in 2009 with a group of entrepreneurs coming from elite multinational companies: their dream was to establish local distribution in the UAE and Oman with multinational standards.

Since day one our approach was therapy, market, and product development. We are always seeking to expand through identifying market needs and introducing the latest trends in healthcare to our local markets. We conduct our business based on best practices and standardized operations while holding ourselves to the highest compliance and ethical standards. We embrace technology and we use it to improve productivity, communication, collaboration, morale, and engagement. We believe in building strong partnerships with our customers and suppliers based on win-win situations and long-term relationships. Our scope of operation covers the entire UAE through our Access Medical LLC & Oman through GLE Medical.